Analysis, fate and toxicity of chiral non-steroidal anti-inflammatory drugs in wastewaters and the environment: a review

被引:47
|
作者
Petrie, Bruce [1 ]
Camacho-Munoz, Dolores [1 ]
机构
[1] Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen AB10 7GJ, Scotland
关键词
Emerging contaminant; Enantiomeric fraction; Metabolite; River; Soil; LC-MS; MS; PERSONAL CARE PRODUCTS; SOLID-PHASE EXTRACTION; WASTE-WATER TREATMENT; SIMULTANEOUS ENANTIOMERIC ANALYSIS; PHARMACEUTICALLY ACTIVE COMPOUNDS; TANDEM MASS-SPECTROMETRY; MICROWAVE-ASSISTED EXTRACTION; SUBSTITUTED CARBOXYLIC-ACIDS; ENDOCRINE DISRUPTORS; ILLICIT DRUGS;
D O I
10.1007/s10311-020-01065-y
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Non-steroidal anti-inflammatory drugs (NSAIDs) are found in the aquatic environment globally. Such drugs including naproxen, ibuprofen and ketoprofen are chiral molecules. Enantiomers of those drugs have identical physicochemical properties but can behave and interact differently in chiral environments due to differences in their three-dimensional shape. This results in enantiospecific differences in environmental fate and toxicity, which is often overlooked. Therefore, we review the analytical methods, occurrence and fate, and toxicity of chiral non-steroidal anti-inflammatory drugs at the enantiomeric level. The advancement of enantioselective chromatography methods, particularly the use of polysaccharide-based stationary phases, has enabled trace determination of enantiomers in complex environmental matrices. Macrocosm and microcosm studies of engineered and natural environments revealed that such drugs can undergo both enantioselective degradation and chiral inversion. Enantioselectivity has been reported during wastewater treatment, in surface waters and in agricultural soils. The use of microcosms spiked with individual enantiomers over racemates is essential to evaluate these degradation and inversion fate processes. The chiral inversion process whereby one enantiomer converts into its antipode can be significant if the more toxic enantiomers are formed. Existing enantiospecific effect studies report less than an order of magnitude difference in enantiomer toxicity. However, toxicity data for enantiomers are limited and further research is needed to better appreciate the environmental risk at the enantiomeric level.
引用
收藏
页码:43 / 75
页数:33
相关论文
共 50 条
  • [21] Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs
    Rubenstein, JH
    Laine, L
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (04) : 373 - 380
  • [22] Review: Cardiovascular complications of non-steroidal anti-inflammatory drugs
    Fosslien, E
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (04): : 347 - 385
  • [23] Potency of non-steroidal anti-inflammatory drugs in chemotherapy (Review)
    Hil'ovska, Lucia
    Jendzelovsky, Rastislav
    Fedorocko, Peter
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (01) : 3 - 12
  • [24] Drug Utilization Review on Non-Steroidal Anti-Inflammatory Drugs
    Thadanki, Madhuri Iatha
    Ahmadi, Ayesha
    Mounika, K. Geetha
    Pravallika, V
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, 10 (04): : P60 - P69
  • [25] Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs
    Lane, Majella E.
    Kim, Mi-Jeong
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (10) : 1295 - 1304
  • [26] Non-steroidal Anti-Inflammatory Drugs and Melanoma
    Sanz-Motilva, Virginia
    Martorell-Calatayud, Antonio
    Nagore, Eduardo
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (26) : 3966 - 3978
  • [27] ASTHMA AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    SZCZEKLIK, A
    GRYGLEWSKI, RJ
    NIZANKOWSKA, E
    ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) : 126 - 127
  • [28] Safety of non-steroidal anti-inflammatory drugs
    Weintraub, William S.
    EUROPEAN HEART JOURNAL, 2017, 38 (44) : 3293 - 3295
  • [29] Pharmacogenetics of non-steroidal anti-inflammatory drugs
    Rollason, V.
    Samer, C.
    Desmeules, J. A.
    DOULEUR ET ANALGESIE, 2013, 26 (04): : 195 - 202
  • [30] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND CYTOTOXICS
    POWLES, TJ
    MILLAR, JL
    CANCER TREATMENT REVIEWS, 1979, 6 : 63 - 67